1. INTRODUCTION

From a physiological standpoint, traditional oral-only cycles using non-aromatizing compounds (Anavar, Winstrol, Turinabol, Oral Primobolan…) are generally suboptimal and, in most cases, counterproductive.

The primary limitation of these cycles is the near-complete absence of circulating estradiol, a metabolite that plays a critical role in anabolism, joint health, lipid metabolism, mood, and neuroprotection during supraphysiological androgen exposure.

Without an exogenous source of estrogenic activity, the user rapidly enters a state of functional hypogonadism characterized by:

• Markedly suppressed endogenous testosterone production
• Subphysiological estradiol levels
• Impaired IGF-1 signaling and satellite-cell proliferation
• Deterioration of mood, libido, and training drive
• Accelerated catabolism (muscle loss) post-cycle

For an oral-only cycle to be considered feasible and tolerable, one of the following conditions must be met:

1. The primary compound must aromatize to a potent estrogen (such as Dianabol).
2. A separate oral “testosterone/estrogen base” must be co-administered to maintain minimal physiological levels of estradiol

2. VIABLE ORAL-ONLY CYCLE EXAMPLES

1. Dianabol-Only Cycle

The only true standalone oral cycle with decades of clinical and anecdotal validation.

• Dosage: 20–40 mg/day (divided doses)
• Duration: 4–6 weeks
• Rationale: Provides both androgenic/anabolic stimulus and sufficient aromatization to methylestradiol to prevent hypoestrogenic sides.

2. Non-Aromatizing Oral + Oral Hormonal Base

Compounds such as Anavar, Turinabol or Winstrol + one of the following bases run from the beginning of the cycle until end of PCT:

• Enclomiphene citrate 12.5–25 mg/day (preferred — maintains endogenous LH/FSH and provides physiological testosterone/estradiol)
• High-dose DHEA 100–200 mg/day (weak precursor support; least effective but widely available)
• Micronized estradiol hemihydrate 0.5–2 mg/day (direct E2 replacement; requires careful titration and monitoring)

Out of these options, Enclomiphene tends to be the safest and most reliable one. For those who do not mind subcutaneous injections, using HCG at 1000iu per week as a hormonal base is also a viable strategy.

4. BLOODWORK AND HARM MITIGATION

• Comprehensive bloodwork (CBC, CMP, Lipid panel, Hormone panel including total/free testosterone, estradiol, SHBG, LH, FSH) at baseline and a few weeks post-cycle.
• Hepatoprotection: TUDCA ≥750 mg/day or NAC ≥1800 mg/day throughout and for ≥4 weeks after.
• Cardiovascular management: Omega 3, Citrus Bergamot, Nattokinase, Telmisartan (if blood pressure increases).
• Structured PCT initiated immediately upon cessation (unless enclomiphene was used, in which case it should be continued for 4 weeks post-cycle).

5. CONCLUSION

Oral-only cycles are physiologically feasible only when estradiol support is explicitly provided, either through Dianabol’s intrinsic aromatization or the co-administration of an oral hormonal base (preferably enclomiphene).
Injectable Testosterone and other injectable anabolics will always be the superior option for those who prioritise health and seek the best possible results.